Kelly Brogan is a true inspiration. She boldly teaches how the traditional narrative surrounding anxiety and depression is based on victim consciousness, with the individual encouraged to view their illness as an existential question that only they can answer. Reframing this perspective, on the other hand, can lead to an invitation to investigate where fulfillment is lacking in one’s life and embark on a hero’s journey that includes a dark night of the soul and the discovery of one’s own courage.
The goal is to achieve 360-degree self-relating and break through the shame walls of self-rejection, self-betrayal, and self-abandonment in order to claim one’s valuable gems. The journey begins with the reclaiming of choice, and readiness is critical to success. The dominant narrative promotes victimization, in which individuals are encouraged to rely on the system, doctors, experts, and gurus to solve their problems. However, the path to self-love and acceptance entails making positive choices in one’s life, such as what one eats, drinks, and thinks.
The traditional medical system is based on a victim triangle in which the patient fights themselves with the assistance of the system, resulting in an endless parade of suffering. The military model pervades the medical system, as evidenced by the names of medications. There is no valid evidence to support the concept of a chemical imbalance, particularly in relation to serotonin and depression.
Antidepressants may aggravate symptoms and only provide benefits by causing the body to adapt to poison. Most drugs do not work in the majority of patients, and pharmaceutical companies’ direct-to-consumer advertising shapes dominant thought forms. To make informed treatment decisions, it is critical to be well-versed in the body of scientific literature and research.
Antidepressant medication approval requires only two studies, which can lead to data manipulation and a positive spin on negative results. Irving Kirsch, a psychiatric whistleblower, discovered that antidepressants outperformed placebo in less than half of the trials, and the overall difference was insignificant. The nature of the study design, as well as the active placebo effect, call into question the true efficacy of antidepressants. When evaluating the outcomes of antidepressant use, it is critical to assess the participants’ mindset.